Company Filing History:
5 out of 5 
1 out of 647 
1 out of 3,687 
Years Active: 2009-2019
Title: The Innovative Contributions of Erik Schwiebert
Introduction
Erik Schwiebert is a notable inventor based in Birmingham, Alabama, recognized for his significant contributions to the field of medical research and treatment. With a total of seven patents to his name, Schwiebert has focused on developing innovative compounds and methods aimed at addressing various hyperproliferative diseases.
Latest Patents
Among his latest patents, Schwiebert has developed coumarin derivative compounds that are designed for the treatment of hyperproliferative diseases, including cancer, polycystic kidney disease, and fibrosis of different tissues, such as idiopathic pulmonary fibrosis. These methods involve administering specific compounds to subjects to inhibit the interaction between heat shock protein chaperones within cells. Additionally, he has created novel CFTR corrector compounds that effectively rescue halide efflux and improve the processing of the delF508-CFTR protein, which is crucial for treating cystic fibrosis and chronic obstructive pulmonary disease. These methods also include administering CFTR corrector compounds or their pharmaceutically acceptable salts or prodrugs.
Career Highlights
Throughout his career, Schwiebert has worked with various organizations, including DiscoveryBioMed, Inc. and the UAB Research Foundation. His work has significantly advanced the understanding and treatment of diseases related to protein misfolding and hyperproliferation.
Collaborations
Some of his notable coworkers include John Streiff and John Dixon, who have collaborated with him on various research projects and patent developments.
Conclusion
Erik Schwiebert's innovative work in developing treatments for serious medical conditions showcases his dedication to improving patient outcomes through scientific research. His contributions continue to influence the field of medical treatment and patent innovation.